Cleared Traditional

K821266 - BBL DIRECTIGEN MENINGITIS TEST KIT
(FDA 510(k) Clearance)

Jun 1982
Decision
29d
Days
Class 2
Risk

K821266 is an FDA 510(k) clearance for the BBL DIRECTIGEN MENINGITIS TEST KIT. This device is classified as a Antisera, All Types, H. Influenza (Class II - Special Controls, product code GRP).

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Washington, US). The FDA issued a Cleared decision on June 1, 1982, 29 days after receiving the submission on May 3, 1982.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3300.

Submission Details

510(k) Number K821266 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 03, 1982
Decision Date June 01, 1982
Days to Decision 29 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary

Device Classification

Product Code GRP — Antisera, All Types, H. Influenza
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3300